Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, Chan FKL, Sung JJY, Kaplan GG, Ng SC (2017) Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis Gastroenterology. 153(2):420–429. https://doi.org/10.1053/j.gastro.2017.04.022

Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E (2018) Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health. Organ Reg Gastroenterol 155(5):1372–1382e17. https://doi.org/10.1053/j.gastro.2018.07.007

Article  Google Scholar 

Perez-Perez GI, Rothenbacher D, Brenner H (2004) Epidemiology of Helicobacter pylori infection Helicobacter 9 Suppl 1:1–6. https://doi.org/10.1111/j.1083-4389.2004.00248.x

Karczewska E, Klesiewicz K, Skiba I, Wojtas-Bonior I, Sito E, Czajecki K, Zwolińska-Wcisło M, Budak A (2012) Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland. Gastroenterol Res Pract 2012:418010. https://doi.org/10.1155/2012/418010

Article  PubMed  PubMed Central  Google Scholar 

Korona-Glowniak I, Cichoz-Lach H, Siwiec R, Andrzejczuk S, Glowniak A, Matras P, Malm A (2019) Antibiotic Resistance and Genotypes of Helicobacter pylori Strains in Patients with Gastroduodenal Disease in Southeast Poland. J Clin Med 21(7):1071. https://doi.org/10.3390/jcm8071071

Article  CAS  Google Scholar 

Karczewska E, Klesiewicz K, Nowak P, Sito E, Skiba I, Zwoliska-Wcisło M, Mach T, Budak A (2014) Empirical Versus Targeted Treatment of Helicobacter pylori Infections in Southern Poland According to the Results of Local Antimicrobial Resistance Monitoring Trends in Helicobacter pylori Infection. InTech. https://doi.org/10.5772/57387

Article  Google Scholar 

Ando T, Goto Y, Maeda O, Watanabe O, Ishiguro K, Goto H (2006) Causal role of Helicobacter pylori infection in gastric cancer. World J Gastroenterol 14(122):181–186. https://doi.org/10.3748/wjg.v12.i2.181

Article  Google Scholar 

Schistosomes (1994) liver flukes and Helicobacter pylori IARC Monogr Eval Carcinog Risks Hum. 61:1–241

Konturek PC, Konturek SJ, Brzozowski T (2009) Helicobacter pylori infection in gastric cancerogenesis. J Physiol Pharmacol 60(3):3–21

PubMed  CAS  Google Scholar 

Jaguszyn-Krynicka EK, Gajkowska A, Godlewska R (1993) Virulence factors of Helicobacter. pylori Mikrobiol Med 3(20):3–13 Article In Polish

Google Scholar 

Wroblewski LE, Peek RM Jr, Wilson KT (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23(4):713–739. https://doi.org/10.1128/CMR.00011-10

Article  PubMed  PubMed Central  CAS  Google Scholar 

Crabtree JE, Covacci A, Farmery SM, Xiang Z, Tompkins DS, Perry S, Lindley IJ, Rappuoli R (1995) Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol 48(1):41–45. https://doi.org/10.1136/jcp.48.1.41

Article  PubMed  PubMed Central  CAS  Google Scholar 

Polk DB, Peek RM Jr. (2010) Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer.;10(6):403– 14. https://doi.org/10.1038/nrc2857. Erratum in: Nat Rev Cancer. 2010;10(8):593. PMID: 20495574; PMCID: PMC2957472

Wueppenhorst N, Stueger HP, Kist M, Glocker E (2009) Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany. J Antimicrob Chemother 63(4):648–653. https://doi.org/10.1093/jac/dkp003

Article  PubMed  CAS  Google Scholar 

Essawi T, Hammoudeh W, Sabri I, Sweidan W, Farraj MA (2013) Determination of Helicobacter pylori Virulence Genes in Gastric Biopsies by PCR. ISRN Gastroenterol. 2013:606258. https://doi.org/10.1155/2013/606258

Peek RM Jr, Crabtree JE (2006) Helicobacter infection and gastric neoplasia. J Pathol 208(2):233–248. https://doi.org/10.1002/path.1868

Article  PubMed  CAS  Google Scholar 

Peek RM Jr. (2005) Pathogenesis of Helicobacter pylori infection. Springer Semin Immunopathol. Sep;27(2):197–215. https://doi.org/10.1007/s00281-005-0204-8. Epub 2005 Jun 1. PMID: 15928915

Palli D, Masala G, Del Giudice G, Plebani M, Basso D, Berti D, Numans ME, Ceroti M, Peeters PH, Bueno de Mesquita HB, Buchner FL, Clavel-Chapelon F, Boutron-Ruault MC, Krogh V, Saieva C, Vineis P, Panico S, Tumino R, Nyrén O, Simán H, Berglund G, Hallmans G, Sanchez MJ, Larrãnaga N, Barricarte A, Navarro C, Quiros JR, Key T, Allen N, Bingham S, Khaw KT, Boeing H, Weikert C, Linseisen J, Nagel G, Overvad K, Thomsen RW, Tjonneland A, Olsen A, Trichoupoulou A, Trichopoulos D, Arvaniti A, Pera G, Kaaks R, Jenab M, Ferrari P, Nesi G, Carneiro F, Riboli E, Gonzalez CA (2007) CagA + Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 15(4):859–867. https://doi.org/10.1002/ijc.22435

Article  CAS  Google Scholar 

Gocki J, Bartuzi Z, Dziedziczko A (2003) Cytotoxity genes of Helicobacter pylori. Ann Academiae Medicae Bydgostiensis 17(2):65–70 Article In Polish

Google Scholar 

Kuklińska U, Łasica AM, Jagusztyn-Krynicka EK (2011) Białko CagA Helicobacter pylori- pierwsza zidentyfikowana bakteryjna onkoproteina. Post Mikrobiol 50(2):97–106 Article In Polish

Google Scholar 

Chen XJ, Yan J, Shen YF (2005) Dominant cagA/vacA genotypes and coinfection frequency of H. pylori in peptic ulcer or chronic gastritis patients in Zhejiang Province and correlations among different genotypes, coinfection and severity of the diseases. Chin Med J (Engl) 20(6):460–467

Google Scholar 

Garner JA, Cover TL (1995) Analysis of genetic diversity in cytotoxin-producing and non-cytotoxin-producing Helicobacter pylori strains J Infect Dis 172(1):290-3. https://doi.org/10.1093/infdis/172.1.290

Takahashi-Kanemitsu A, Knight CT, Hatakeyama M Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis (2020). Cell Mol Immunol 17(1):50–63. https://doi.org/10.1038/s41423-019-0339-5

Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ (2012) European Helicobacter Study Group Management of Helicobacter pylori infection–the Maastricht. IV/ Florence Consensus Rep Gut 61(5):646–664. https://doi.org/10.1136/gutjnl-2012-302084

Article  CAS  Google Scholar 

Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, Gasbarrini A, Hunt RH, Leja M, O’Morain C, Rugge M, Suerbaum S, Tilg H, Sugano K, El-Omar EM (2022) European Helicobacter and Microbiota Study group Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report Gut 8:gutjnl-2022-327745. https://doi.org/10.1136/gutjnl-2022-327745

Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, Mégraud F, Xiao SD, Sugano K, Nyrén O, Lejondal H, pylori-Gastric Cancer Task Force (2005) Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol 92100–2115. https://doi.org/10.1111/j.1572-0241.2005.41688.x

Krzyżek P, Pawełka D, Iwańczak B, Kempiński R, Leśniakowski K, Mégraud F, Łaczmański Ł, Biernat M, Gościniak G (2020) High Primary Antibiotic Resistance of Helicobacter pylori Strains Isolated from Pediatric and Adult Patients in Poland during 2016–2018 Antibiotics (Basel) 2;9(5):228. https://doi.org/10.3390/antibiotics9050228

Karczewska E, Wojtas-Bonior I, Sito E, Zwolińska-Wcisło M, Budak A (2011) Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern. Pol Pharmacol Rep 63(3):799–807. https://doi.org/10.1016/s1734-1140(11)70592-8

Article  CAS  Google Scholar 

The European Committee on Antimicrobial Susceptibility Testing (2023) Breakpoint tables for interpretation of MICs and zone diameters. Version 13.1, http://www.eucast.org

Kargar M, Ghorbani-Dalini S, Doosti A, Souod N (2012) Real-time PCR for Helicobacter pylori quantification and detection of clarithromycin resistance in gastric tissue from patients with gastrointestinal. disorders Res Microbiol 163(2):109–113. https://doi.org/10.1016/j.resmic.2011.11.005

Article  PubMed  CAS  Google Scholar 

Clayton CL, Kleanthous H, Morgan DD, Puckey L, Tabaqchali S (1993) Rapid fingerprinting of Helicobacter pylori by polymerase chain reaction and restriction fragment length polymorphism analysis. J Clin Microbiol 31(6):1420–1425. https://doi.org/10.1128/jcm.31.6.1420-1425.1993

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cambau E, Allerheiligen V, Coulon C, Corbel C, Lascols C, Deforges L, Soussy CJ, Delchier JC, Megraud F (2009) Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori. J Clin Microbiol 47(11):3600–3607. https://doi.org/10.1128/JCM.00744-09

Article  PubMed  PubMed Central  CAS  Google Scholar 

GenoType HelicoDR VER 1.0 Instructions for Use IFU-337-09

Chen YC, Malfertheiner P, Yu HT, Kuo CL, Chang YY, Meng FT, Wu YX, Hsiao JL, Chen MJ, Lin KP, Wu CY, Lin JT, O’Morain C, Megraud F, Lee WC, El-Omar EM, Wu MS, Liou JM (2024) Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022 Gastroenterology. 166(4):605–619. https://doi.org/10.1053/j.gastro.2023.12.022

Brandi G, Biavati B, Calabrese C, Granata M, Nannetti A, Mattarelli P, Di Febo G, Saccoccio G, Biasco G (2006) Urease-positive bacteria other than Helicobacter pylori in human gastric juice and mucosa. Am J Gastroenterol 101(8):1756–1761. https://doi.org/10.1111/j.1572-0241.2006.00698.x

Article  PubMed  Google Scholar 

Rastawicki W, Wiechetek-Płaza K (2023) Seroprevalence of Helicobacter pylori infections in children and adults in Poland in the years 2020–2023. Przegl Epidemiol 77(3):317–326. https://doi.org/10.32394/pe.77.29

Article  PubMed  Google Scholar 

Hatakeyama M (2004) Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer.;4(9):688– 94. https://doi.org/10.1038/nrc1433. PMID: 15343275

Hays C, Burucoa C, Lehours P, Tran CT, Leleu A, Raymond J (2018) Molecular characterization of Helicobacter pylori resistance to rifamycins Helicobacter 23(1). https://doi.org/10.1111/hel.12451

Glocker E, Bogdan C, Kist M (2007) Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany. J Antimicrob Chemother 59(5):874–879. https://doi.org/10.1093/jac/dkm039

Article  PubMed  CAS  Google Scholar 

Heep M, Beck D, Bayerdörffer E, Lehn N (1999) Rifampin and rifabutin resistance mechanism in Helicobacter pylori. Antimicrob Agents Chemother 43(6):1497–1499. https://doi.org/10.1128/AAC.43.6.1497

Article  PubMed  PubMed Central  CAS  Google Scholar 

Borkowska-Tatar D, Zabost A, Kozińska M, Augustynowicz-Kopeć E (2022) Tuberculosis in Poland: Epidemiological and Molecular Analysis during the COVID-19 Pandemic. Diagnostics (Basel) 3;12(8):1883. https://doi.org/10.3390/diagnostics12081883

Bilgilier C, Stadlmann A, Makristathis A, Thannesberger J, Kastner MT, Knoflach P, Steiner P, Schöniger-Hekele M, Högenauer C, Blesl A, Datz C, Huber-Schönauer U, Schöfl R, Wewalka F, Püspök A, Mitrovits N, Leiner J, Tilg H, Effenberger M, Moser M, Siebert F, Hinterberger I, Wurzer H, Stupnicki T, Watzinger N, Gombotz G, Hubmann R, Klimpel S, Biowski-Frotz S, Schrutka-Kölbl C, Graziadei I, Ludwiczek O, Kundi M, Hirschl AM, Steininger C, Austrian Helicobacter Study Group of the Austrian Society of Gastroenterology and Hepatology (2018) Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori. Clin Microbiol Infect 24(3):267–272. https://doi.org/10.1016/j.cmi.2017.06.025

Article  PubMed  CAS